Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Children's Mercy Kansas City, Kansas City, MO, USA.
Curr Psychiatry Rep. 2020 Feb 1;22(2):9. doi: 10.1007/s11920-020-1127-8.
Although treatment algorithms and parameters for best practice are readily available for all major syndromes of psychiatric impairment, the occurrence of psychiatric syndromes in individuals with intellectual and developmental disability (IDD) invokes serious contextual challenges for interpretation of symptoms, diagnosis, and optimization of treatment, both for clinicians and for the service sectors in which care and support of individuals with IDD are delivered. Recognizing that there exist very few definitive resources for best practice under the circumstance of this form of "dual diagnosis," the Missouri Department of Mental Health convened an expert panel to conduct a focused review and synthesis of the relevant scientific literature from which to develop guidance in the form of decision support to clinicians. This article summarizes the findings for three of the most common and impairing clusters of psychiatric symptoms that co-occur with IDD-aggression, depression, and addictions.
Individuals with IDD are at high risk for the development of psychiatric symptoms (PS), which often manifest uniquely in IDD and for which evidence for effective intervention is steadily accruing. Interventions that are commonly implemented in the IDD service sector (e.g., functional communication training and positive behavioral support planning) are capable of mitigating severe behavioral impairment, yet rarely invoked when dual diagnosis patients are seen in the psychiatric service sector. Conversely, state-of-the-art interventions for traumatic stress, pharmacotherapy, and psychotherapy have proven capable of improving behavioral impairments in IDD but are typically restricted to the psychiatric service sector, where there exist significant barriers to access for patients with IDD, including limitations imposed by diagnostic eligibility and practitioner experience. Bridging these gaps in knowledge and clinical capacity across the respective IDD and PS service sectors should be of very high priority in strategizing the care and support of IDD patients with serious co-occurring psychiatric conditions.
尽管针对所有主要精神障碍综合征,都有现成的最佳实践治疗方案和参数,但对于智力和发育障碍(ID)个体中出现的精神障碍综合征,其症状的解释、诊断和治疗优化都存在严重的背景挑战,这对临床医生和提供 ID 个体照护和支持的服务部门来说都是如此。鉴于在这种“双重诊断”的情况下,实际上几乎没有针对最佳实践的明确资源,密苏里州心理健康部召集了一个专家小组,对相关科学文献进行了重点回顾和综合,以制定决策支持工具来为临床医生提供指导。本文总结了与 ID 共病的三种最常见和最具致残性的精神障碍症状集群的发现,即攻击性、抑郁和成瘾。
ID 个体患精神症状(PS)的风险很高,这些症状在 ID 中经常表现独特,且针对其的有效干预措施证据不断增加。在 ID 服务部门中实施的干预措施(例如,功能性沟通训练和积极行为支持计划)能够减轻严重的行为障碍,但在精神科服务部门中很少针对双重诊断患者使用。相反,创伤后应激障碍、药物治疗和心理治疗的最新干预措施已被证明能够改善 ID 中的行为障碍,但通常仅限于精神科服务部门,而 ID 患者在该部门存在严重的服务获取障碍,包括诊断资格和从业者经验方面的限制。在制定 ID 患者严重共病精神障碍的照护和支持策略时,应将跨 ID 和 PS 服务部门的这些知识和临床能力差距作为非常高的优先事项。